Loading clinical trials...
Loading clinical trials...
Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected
Conditions
Interventions
Leukocyte Interleukin, Injection
Locations
2
United States
Naval Medical Center San Diego
San Diego, California, United States
University of California San Francisco
San Francisco, California, United States
Start Date
April 1, 2015
Primary Completion Date
June 1, 2018
Completion Date
September 1, 2018
Last Updated
September 22, 2023
Lead Sponsor
CEL-SCI Corporation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions